Stock listing
LSE:0I3Q Corcept Therapeutics Incorporated Share Price
UK listing (LSE) of Corcept Therapeutics Incorporated · home listing NASDAQ:CORT
Follow Corcept Therapeutics Incorporated into a list and get an email when it puts out news.
Share price · LSE:0I3Q
$67.82 USD -2.50 (-3.6%)
Close on Nov 18, 2026
- Day range
- $67.40 – $71.50 USDNov 18, 2026
- Volume
- 275 sharesNov 18, 2026
- 52-week range
- $28.67 – $126.57 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $75,422 USDMedian day 412 shares · 1 day with no trades · last 3 months, Aug 18, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CORT · Home | $67.79 USD | -2.28 (-3.3%) | 744,849 | $71.01 | $71.50 | $67.09 | $70.07 | Close on Nov 18, 2026 |
| LSE:0I3Q | $67.82 USD | -2.501 (-3.6%) | 275 | $70.31 | $71.50 | $67.40 | $70.32 | Close on Nov 18, 2026 |
| Frankfurt:HTD | €61.52 EUR | -1.70 (-2.7%) | — | €63.18 | €63.18 | €61.52 | €63.22 | Close on Nov 18, 2026 |
| Munich:HTD | €63.54 EUR | 0.00 (0.0%) | — | €63.54 | €63.54 | €63.54 | €63.54 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 6, 2026 · LSE:0I3Q · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $72.80 | -0.25 | -0.3% | $72.30 | $75.00 | $70.25 | 477 | |
| $73.05 | -4.88 | -6.3% | $76.30 | $79.80 | $73.05 | 375 | |
| $77.93 | -5.95 | -7.1% | $84.39 | $85.10 | $71.67 | 1,075 | |
| $83.88 | +2.79 | +3.4% | $80.01 | $83.88 | $80.01 | 353 | |
| $81.09 | +0.62 | +0.8% | $83.39 | $83.39 | $79.39 | 2,234 | |
| $80.47 | -5.06 | -5.9% | $86.36 | $87.24 | $80.37 | 417 | |
| $85.53 | -1.19 | -1.4% | $85.25 | $88.30 | $85.25 | 406 | |
| $86.72 | -1.03 | -1.2% | $88.00 | $88.19 | $86.00 | 400 | |
| $87.75 | +1.62 | +1.9% | $87.00 | $88.00 | $85.19 | 212 | |
| $86.13 | -2.43 | -2.7% | $85.50 | $91.82 | $82.39 | 1,141 | |
| $88.56 | -20.40 | -18.7% | $107.00 | $109.15 | $85.40 | 2,588 | |
| $108.96 | -8.104 | -6.9% | $114.40 | $115.45 | $108.75 | 711 | |
| $117.06 | +1.24 | +1.1% | $120.00 | $120.00 | $116.21 | 164 | |
| $115.82 | +3.345 | +3.0% | $111.00 | $116.90 | $110.37 | 301 | |
| $112.47 | +3.865 | +3.6% | $108.00 | $112.78 | $108.00 | 263 | |
| $108.61 | -4.98 | -4.4% | $112.11 | $113.33 | $107.78 | 905 | |
| $113.59 | -6.43 | -5.4% | $117.45 | $118.12 | $113.16 | 578 | |
| $120.02 | +2.37 | +2.0% | $117.02 | $121.95 | $117.02 | 2,372 | |
| $117.65 | -2.945 | -2.4% | $119.50 | $123.21 | $117.54 | 402 | |
| $120.60 | -1.555 | -1.3% | $120.00 | $122.12 | $117.02 | 600 | |
| $122.15 | +3.92 | +3.3% | $117.56 | $122.29 | $117.16 | 412 | |
| $118.23 | -2.21 | -1.8% | $119.95 | $121.00 | $115.79 | 322 | |
| $120.44 | +1.17 | +1.0% | $123.56 | $123.56 | $117.84 | 441 | |
| $119.27 | -1.254 | -1.0% | $122.20 | $122.97 | $115.01 | 3,453 | |
| $120.52 | +4.224 | +3.6% | $115.92 | $121.27 | $115.43 | 346 | |
| $116.30 | +2.17 | +1.9% | $113.50 | $117.31 | $113.05 | 301 | |
| $114.13 | -1.12 | -1.0% | $117.41 | $118.05 | $112.08 | 378 | |
| $115.25 | -0.47 | -0.4% | $116.00 | $117.07 | $113.91 | 94 | |
| $115.72 | +0.417 | +0.4% | $116.10 | $120.50 | $113.26 | 1,445 | |
| $115.30 | -0.187 | -0.2% | $116.96 | $117.56 | $114.00 | 299 | |
| $115.49 | +1.498 | +1.3% | $116.65 | $121.00 | $115.44 | 304 | |
| $113.99 | +1.841 | +1.6% | $114.14 | $115.53 | $111.41 | 60 | |
| $112.15 | -6.85 | -5.8% | $117.50 | $120.05 | $112.15 | 260 | |
| $119.00 | +2.53 | +2.2% | $114.50 | $119.00 | $113.95 | 227 | |
| $116.47 | +3.48 | +3.1% | $112.19 | $116.47 | $105.57 | 1,658 | |
| $112.99 | +0.18 | +0.2% | $119.79 | $120.10 | $112.58 | 391 | |
| $112.81 | +0.55 | +0.5% | $114.00 | $114.00 | $112.03 | 151 | |
| $112.26 | +1.56 | +1.4% | $111.45 | $112.72 | $109.38 | 144 | |
| $110.70 | -2.04 | -1.8% | $112.80 | $112.99 | $109.61 | 1,103 | |
| $112.74 | +1.86 | +1.7% | $109.00 | $114.37 | $109.00 | 269 | |
| $110.88 | -3.98 | -3.5% | $116.94 | $118.01 | $109.02 | 1,045 | |
| $114.86 | -1.66 | -1.4% | $116.20 | $116.27 | $113.96 | 111 | |
| $116.52 | +1.51 | +1.3% | $114.40 | $117.51 | $112.75 | 841 | |
| $115.01 | +3.26 | +2.9% | $111.00 | $115.01 | $107.42 | 1,874 | |
| $111.75 | 0.00 | 0.0% | $111.75 | $111.75 | $111.75 | 0 | |
| $111.75 | -3.16 | -2.7% | $111.55 | $112.80 | $109.81 | 809 | |
| $114.91 | +4.15 | +3.7% | $111.00 | $114.91 | $110.00 | 265 | |
| $110.76 | -1.35 | -1.2% | $110.00 | $115.46 | $108.97 | 889 | |
| $112.11 | -0.582 | -0.5% | $112.58 | $115.70 | $111.89 | 2,534 | |
| $112.69 | -0.928 | -0.8% | $117.16 | $117.16 | $111.26 | 570 | |
| $113.62 | -4.45 | -3.8% | $120.84 | $121.30 | $113.15 | 1,041 | |
| $118.07 | -5.05 | -4.1% | $119.50 | $124.84 | $116.19 | 621 | |
| $123.12 | +0.53 | +0.4% | $126.00 | $126.00 | $121.70 | 98 | |
| $122.59 | +1.33 | +1.1% | $122.70 | $126.00 | $122.09 | 152 | |
| $121.26 | -0.24 | -0.2% | $124.28 | $126.57 | $118.01 | 254 | |
| $121.50 | +1.58 | +1.3% | $121.96 | $123.10 | $121.05 | 442 | |
| $119.92 | +0.41 | +0.3% | $116.15 | $121.49 | $115.83 | 473 | |
| $119.51 | +1.05 | +0.9% | $120.00 | $120.94 | $116.19 | 608 | |
| $118.46 | +1.81 | +1.6% | $118.00 | $120.10 | $115.19 | 524 |
- Ticker
- LSE:0I3Q
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
ESMO Rare Cancers Publishes Case Report Detailing Eight-Year Response to Relacorilant Plus Nab-Paclitaxel in Metastatic Vulvar Cancer
Latest earnings call · Nov 3, 2026
Corcept Therapeutics (NASDAQ:CORT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 49 slides
Calls
Replays
Corcept Therapeutics (NASDAQ:CORT) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 5:00 PM ET
Watch TranscriptCorcept Therapeutics (NASDAQ:CORT) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 5:00 PM ET
Watch TranscriptCorcept Therapeutics (NASDAQ:CORT) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
Nov 3, 2026
Closed $77.93 (-7.1%) on Nov 4, 2026
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Oct 27, 2026
Closed $86.72 (-1.2%) on Oct 28, 2026
Corcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer
Oct 26, 2026
Closed $86.13 (-2.7%) on Oct 26, 2026
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
Oct 20, 2026
Closed $117.06 (+1.1%) on Oct 21, 2026
Corcept Announces Planned Leadership Transition
Sep 23, 2026
Closed $112.15 (-5.8%) on Sep 23, 2026
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)
Sep 18, 2026
Closed $112.99 (+0.2%) on Sep 18, 2026
Corton Capital Inc. Announces Launch of Corton Rosenberg Global Macro Fund
Sep 9, 2026
Closed $116.52 (+1.3%) on Sep 9, 2026
CORRECTION FROM SOURCE: Corton Capital Inc. Announces August 2026 Distributions for the Exchange Traded Fund
Aug 25, 2026
Closed $123.12 (+0.4%) on Aug 26, 2026
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
Jun 17, 2026
Closed $80.75 (-3.7%) on Jun 18, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 49 slides · July 2026
Technical Presentation (2026)
Technical · 15 slides · Apr 23, 2026
SGO Annual Meeting on Women's Cancer 2026
Conference · 18 slides · Apr 10, 2026
ENCALS 2025
Conference · 13 slides · Dec 15, 2025
Corcept Therapeutics Incorporated on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 26 in the last 12 months · 136 in all · newest Nov 16, 2026 · oldest 2019
- Calls
- 26 calls with a replay · 26 with a transcript · latest Nov 3, 2026
- Decks
- 10 decks · latest July 2026
Where Corcept Therapeutics Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CORT · Home listing | NASDAQ | United States | USD |
| gettex:HTD | gettex | Germany | EUR |
| LS Exchange:529882 | LS Exchange | Germany | EUR |
| Lang & Schwarz:529882 | Lang & Schwarz | Germany | EUR |
| BOATS:CORT | BOATS | United States | USD |
| Tradegate:HTD | Tradegate | Germany | EUR |
| Milan:1CORT | Milan | Italy | EUR |
| LSE:0I3Q · This page | LSE | United Kingdom | USD |
| Frankfurt:HTD | Frankfurt | Germany | EUR |
| BX Swiss:HTD | BX Swiss | Switzerland | CHF |
| Dusseldorf:HTD | Dusseldorf | Germany | EUR |
| Hamburg:HTD | Hamburg | Germany | EUR |
| Munich:HTD | Munich | Germany | EUR |
| Stuttgart:HTD | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Corcept Therapeutics Incorporated.